Current Cardiology Reports

, 19:96 | Cite as

Congenital and Acquired Valvular Heart Disease in Pregnancy

  • Sarah A. GoldsteinEmail author
  • Cary C. Ward
Valvular Heart Disease (T Kiefer, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Valvular Heart Disease


Purpose of Review

The number of pregnancies complicated by valvular heart disease is increasing. This review describes the hemodynamic effects of clinically important valvular abnormalities during pregnancy and reviews current guideline-driven management strategies.

Recent Findings

Valvular heart disease in women of childbearing age is most commonly caused by congenital abnormalities and rheumatic heart disease. Regurgitant lesions are well tolerated, while stenotic lesions are associated with a higher risk of pregnancy-related complications. Management of symptomatic disease during pregnancy is primarily medical, with percutaneous interventions considered for refractory symptoms.


Most guidelines addressing the management of valvular heart disease during pregnancy are based on case reports and observational studies. Additional investigation is required to further advance the care of this growing patient population.


Valvular heart disease Structural heart disease Congenital heart disease Rheumatic heart disease Pregnancy 


Compliance with Ethical Standards

Conflict of Interest

Sarah A. Goldstein and Cary C. Ward declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.


Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. 1.
    Creanga AA, et al. Pregnancy-related mortality in the United States, 2006–2010. Obstet Gynecol. 2015;125(1):5–12.PubMedCrossRefGoogle Scholar
  2. 2.
    Gatzoulis, Michael A., et al. Diagnosis and Management of Adult Congenital Heart Disease. 2nd Ed, Elsevier, 2011.Google Scholar
  3. 3.
    Ntiloudi D, et al. Adult congenital heart disease: a paradigm of epidemiological change. Int J Cardiol. 2016;218:269–74.PubMedCrossRefGoogle Scholar
  4. 4.
    Pitkin RM, et al. Pregnancy and congenital heart disease. Ann Intern Med. 1990;112(6):445–54.PubMedCrossRefGoogle Scholar
  5. 5.
    Carbillon L, Uzan M, Uzan S. Pregnancy, vascular tone, and maternal hemodynamics: a crucial adaptation. Obstet Gynecol Surv. 2000;55(9):574–81.PubMedCrossRefGoogle Scholar
  6. 6.
    Ouzounian JG, Elkayam U. Physiologic changes during normal pregnancy and delivery. Cardiol Clin. 2012;30(3):317–29.PubMedCrossRefGoogle Scholar
  7. 7.
    Sanghavi M, Rutherford JD. Cardiovascular physiology of pregnancy. Circulation. 2014;130(12):1003–8.PubMedCrossRefGoogle Scholar
  8. 8.
    Desai DK, Moodley J, Naidoo DP. Echocardiographic assessment of cardiovascular hemodynamics in normal pregnancy. Obstet Gynecol. 2004;104(1):20–9.PubMedCrossRefGoogle Scholar
  9. 9.
    Elkayam U, et al. High-risk cardiac disease in pregnancy: Part II. J Am Coll Cardiol. 2016;68(5):502-516.Google Scholar
  10. 10.
    Hinze A, et al. Reproductive and contraceptive counseling received by adult women with congenital heart disease: a risk-based analysis. Congenit Heart Dis. 2013;8(1):20–31.PubMedCrossRefGoogle Scholar
  11. 11.
    Siu SC, et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation. 2001;104(5):515–21.PubMedCrossRefGoogle Scholar
  12. 12.
    Drenthen W, et al. Predictors of pregnancy complications in women with congenital heart disease. Eur Heart J. 2010;31(17):2124–32.PubMedCrossRefGoogle Scholar
  13. 13.
    Thorne S, MacGregor A, Nelson-Piercy C. Risks of contraception and pregnancy in heart disease. Heart. 2006;92(10):1520–5.PubMedPubMedCentralCrossRefGoogle Scholar
  14. 14.
    • Balci A, et al. Prospective validation and assessment of cardiovascular and offspring risk models for pregnant women with congenital heart disease. Heart. 2014; doi: 10.1136/heartjnl-2014-305597. Excellent analysis of the risk models that inform pre-pregnancy counseling.
  15. 15.
    Ohuchi H, et al. Cardiopulmonary variables during exercise predict pregnancy outcome in women with congenital heart disease. Circ J. 2013;77(2):470–6.PubMedCrossRefGoogle Scholar
  16. 16.
    Lui GK, et al. Heart rate response during exercise and pregnancy outcome in women with congenital heart disease. Circulation. 2011;123(3):242–8.PubMedCrossRefGoogle Scholar
  17. 17.
    Khairy P, et al. Pregnancy outcomes in women with congenital heart disease. Circulation. 2006;113(4):517–24.PubMedCrossRefGoogle Scholar
  18. 18.
    Reimold SC, Rutherford JD. Valvular heart disease in pregnancy. N Engl J Med. 2003;349(1):52–9.Google Scholar
  19. 19.
    Hameed A, et al. The effect of valvular heart disease on maternal and fetal outcome of pregnancy. J Am Coll Cardiol. 2001;37(3):893–9.PubMedCrossRefGoogle Scholar
  20. 20.
    John AS, et al. Cardiopulmonary bypass during pregnancy. Ann Thorac Surg. 2011;91(4):1191–6.PubMedCrossRefGoogle Scholar
  21. 21.
    Weiss BM, et al. Outcome of cardiovascular surgery and pregnancy: a systematic review of the period 1984–1996. Am J Obstet Gynecol. 1998;179(6):1643–53.PubMedCrossRefGoogle Scholar
  22. 22.
    Wilson W, et al. Prevention of infective endocarditis. Circulation. 2007;116(15):1736–54.PubMedCrossRefGoogle Scholar
  23. 23.
    Yap SC, et al. Aortic stenosis at young adult age. Expert Rev Cardiovasc Ther. 2005;3(6):1087–98.PubMedCrossRefGoogle Scholar
  24. 24.
    Arias F, Pineda J. Aortic stenosis and pregnancy. J Reprod Med. 1978;20(4):229–32.PubMedGoogle Scholar
  25. 25.
    Orwat S, et al. Risk of pregnancy in moderate and severe aortic stenosis: from the multinational ROPAC Registry. J Am Coll Cardiol. 2016;68(16):1727–37.PubMedCrossRefGoogle Scholar
  26. 26.
    Silversides CK, et al. Early and intermediate-term outcomes of pregnancy with congenital aortic stenosis. Am J Cardiol. 2003;91(11):1386–9.PubMedCrossRefGoogle Scholar
  27. 27.
    Yap SC, et al. Risk of complications during pregnancy in women with congenital aortic stenosis. Int J Cardiol. 2008;126(2):240–6.PubMedCrossRefGoogle Scholar
  28. 28.
    Nishimura RA, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg. 2014;148(1):e1–e132.PubMedCrossRefGoogle Scholar
  29. 29.
    Warnes CA, et al. ACC/AHA 2008 guidelines for the Management of Adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines on the management of adults with congenital heart disease). Circulation. 2008;118(23):e714–833.PubMedCrossRefGoogle Scholar
  30. 30.
    Myerson SG, et al. What is the role of balloon dilatation for severe aortic stenosis during pregnancy? J Heart Valve Dis. 2005;14(2):147–50.PubMedGoogle Scholar
  31. 31.
    Tzemos N, et al. Late cardiac outcomes after pregnancy in women with congenital aortic stenosis. Am Heart J. 2009;157(3):474–80.PubMedCrossRefGoogle Scholar
  32. 32.
    Tadros TM, Klein MD, Shapira OM. Ascending aortic dilatation associated with bicuspid aortic valve. Circulation. 2009;119(6):880–90.PubMedCrossRefGoogle Scholar
  33. 33.
    • Regitz-Zagrosek V, et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy. Eur Heart J. 2011; doi: 10.1093/eurheartj/ehr218. Only source of specific practice guidelines for management of cardiovascular disease and pregnancy.
  34. 34.
    Silversides CK, et al. Cardiac risk in pregnant women with rheumatic mitral stenosis. Am J Cardiol. 2003;91(11):1382–5.PubMedCrossRefGoogle Scholar
  35. 35.
    Lesniak-Sobelga A, et al. Clinical and echocardiographic assessment of pregnant women with valvular heart diseases—maternal and fetal outcome. Int J Cardiol. 2004;94(1):15–23.PubMedCrossRefGoogle Scholar
  36. 36.
    al Kasab SM, et al. Beta-adrenergic receptor blockade in the management of pregnant women with mitral stenosis. Am J Obstet Gynecol. 1990;163(1 Pt 1):37–40.PubMedCrossRefGoogle Scholar
  37. 37.
    Sivadasanpillai H, et al. Long-term outcome of patients undergoing balloon mitral valvotomy in pregnancy. Am J Cardiol. 2005;95(12):1504–6.PubMedCrossRefGoogle Scholar
  38. 38.
    Esteves CA, et al. Immediate and long-term follow-up of percutaneous balloon mitral valvuloplasty in pregnant patients with rheumatic mitral stenosis. Am J Cardiol. 2006;98(6):812–6.PubMedCrossRefGoogle Scholar
  39. 39.
    Fuster V, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation). Eur Heart J. 2006;27(16):1979–2030.PubMedCrossRefGoogle Scholar
  40. 40.
    Elkayam U, Bitar F. Valvular heart disease and pregnancy part I: native valves. J Am Coll Cardiol. 2005;46(2):223–30.PubMedCrossRefGoogle Scholar
  41. 41.
    Siu SC, et al. Risk and predictors for pregnancy-related complications in women with heart disease. Circulation. 1997;96(9):2789–94.PubMedCrossRefGoogle Scholar
  42. 42.
    Drenthen W, et al. Non-cardiac complications during pregnancy in women with isolated congenital pulmonary valvar stenosis. Heart. 2006;92(12):1838–43.PubMedPubMedCentralCrossRefGoogle Scholar
  43. 43.
    Hameed A, Youdim K, Mehboob A, Goodwin TM, Wing D, Elkayam U. Effect of the severity of pulmonary stenosis on pregnancy outcomes-a case control study. Am J Obstet Gynecol. 2004;191(6):S93.CrossRefGoogle Scholar
  44. 44.
    Brickner ME. Cardiovascular management in pregnancy: congenital heart disease. Circulation. 2014;130(3):273–82.PubMedCrossRefGoogle Scholar
  45. 45.
    Roberts WC, et al. Causes of pure aortic regurgitation in patients having isolated aortic valve replacement at a single US tertiary hospital (1993 to 2005). Circulation. 2006;114(5):422–9.PubMedCrossRefGoogle Scholar
  46. 46.
    Stout KK, Otto CM. Pregnancy in women with valvular heart disease. Heart. 2007;93(5):552–8.PubMedCrossRefGoogle Scholar
  47. 47.
    Meijer JM, et al. Pregnancy, fertility, and recurrence risk in corrected tetralogy of Fallot. Heart. 2005;91(6):801–5.PubMedPubMedCentralCrossRefGoogle Scholar
  48. 48.
    Greutmann M, et al. Pregnancy outcome in women with congenital heart disease and residual haemodynamic lesions of the right ventricular outflow tract. Eur Heart J. 2010;31(14):1764–70.PubMedCrossRefGoogle Scholar
  49. 49.
    Connolly HM, Warnes CA. Ebstein’s anomaly: outcome of pregnancy. J Am Coll Cardiol. 1994;23(5):1194–8.PubMedCrossRefGoogle Scholar
  50. 50.
    Badduke BR, et al. Pregnancy and childbearing in a population with biologic valvular prostheses. J Thorac Cardiovasc Surg. 1991;102(2):179–86.PubMedGoogle Scholar
  51. 51.
    North RA, et al. Long-term survival and valve-related complications in young women with cardiac valve replacements. Circulation. 1999;99(20):2669–76.PubMedCrossRefGoogle Scholar
  52. 52.
    El SF, et al. Pregnancy has no effect on the rate of structural deterioration of bioprosthetic valves: long-term 18-year follow up results. J Heart Valve Dis. 2005;14(4):481–5.PubMedGoogle Scholar
  53. 53.
    • van Hagen IM, et al. Pregnancy in women with a mechanical heart valve: data of the European Society of Cardiology Registry of Pregnancy and Cardiac Disease (ROPAC). Circulation. 2015;132(2):132–42. Presents newer data about management of mechanical heart valves during pregnancy and provides insight into different anticoagulation regimens. Google Scholar
  54. 54.
    Bremme KA. Haemostatic changes in pregnancy. Best Pract Res Clin Haematol. 2003;16(2):153–68.PubMedCrossRefGoogle Scholar
  55. 55.
    Kujovich JL. Hormones and pregnancy: thromboembolic risks for women. Br J Haematol. 2004;126(4):443–54.PubMedCrossRefGoogle Scholar
  56. 56.
    James AH, et al. Low-molecular-weight heparin for thromboprophylaxis in pregnant women with mechanical heart valves. J Matern Fetal Neonatal Med. 2006;19(9):543–9.PubMedCrossRefGoogle Scholar
  57. 57.
    Steinberg ZL, et al. Maternal and fetal outcomes of anticoagulation in pregnant women with mechanical heart valves. J Am Coll Cardiol. 2017;69(22):2681–91.PubMedPubMedCentralCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2017

Authors and Affiliations

  1. 1.Duke University Medical CenterDurhamUSA

Personalised recommendations